These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 30223493)
1. Cytokine-Modulated Natural Killer Cells Differentially Regulate the Activity of the Hepatitis C Virus. Cho YJ; Lee HH; Kang H; Cho H Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223493 [TBL] [Abstract][Full Text] [Related]
2. IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells. Zhang S; Saha B; Kodys K; Szabo G J Hepatol; 2013 Sep; 59(3):442-9. PubMed ID: 23665181 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3. Yang CM; Yoon JC; Park JH; Lee JM PLoS One; 2017; 12(4):e0175793. PubMed ID: 28410411 [TBL] [Abstract][Full Text] [Related]
4. CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C. Kokordelis P; Krämer B; Boesecke C; Voigt E; Ingiliz P; Glässner A; Wolter F; Srassburg CP; Spengler U; Rockstroh JK; Nattermann J J Acquir Immune Defic Syndr; 2015 Dec; 70(4):338-46. PubMed ID: 26509931 [TBL] [Abstract][Full Text] [Related]
5. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication. Wang XX; Pan XB; Han JC; Cong X; Jin Q; Kong XS; Wei L; Feng B Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):233-240. PubMed ID: 29625837 [TBL] [Abstract][Full Text] [Related]
6. Monocytes inhibit hepatitis C virus-induced TRAIL expression on CD56 Mele D; Mantovani S; Oliviero B; Grossi G; Lombardi A; Mondelli MU; Varchetta S J Hepatol; 2017 Dec; 67(6):1148-1156. PubMed ID: 28803951 [TBL] [Abstract][Full Text] [Related]
7. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host. Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S Virol J; 2016 Apr; 13():59. PubMed ID: 27044429 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection. Crotta S; Brazzoli M; Piccioli D; Valiante NM; Wack A J Hepatol; 2010 Feb; 52(2):183-90. PubMed ID: 20015567 [TBL] [Abstract][Full Text] [Related]
9. Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro. Golden-Mason L; Cox AL; Randall JA; Cheng L; Rosen HR Hepatology; 2010 Nov; 52(5):1581-9. PubMed ID: 20812318 [TBL] [Abstract][Full Text] [Related]
10. Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1. Stegmann KA; Björkström NK; Ciesek S; Lunemann S; Jaroszewicz J; Wiegand J; Malinski P; Dustin LB; Rice CM; Manns MP; Pietschmann T; Cornberg M; Ljunggren HG; Wedemeyer H J Infect Dis; 2012 May; 205(9):1351-62. PubMed ID: 22457290 [TBL] [Abstract][Full Text] [Related]
11. CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes. Ye L; Wang X; Wang S; Wang Y; Song L; Hou W; Zhou L; Li H; Ho W Hepatology; 2009 Mar; 49(3):753-62. PubMed ID: 19085952 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions. Holder KA; Stapleton SN; Gallant ME; Russell RS; Grant MD J Immunol; 2013 Sep; 191(6):3308-18. PubMed ID: 23960237 [TBL] [Abstract][Full Text] [Related]
14. Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation. Tanimine N; Tanaka Y; Abe T; Piao J; Chayama K; Ohdan H Transplantation; 2016 Feb; 100(2):355-64. PubMed ID: 26714120 [TBL] [Abstract][Full Text] [Related]
15. Natural killer cells inhibit hepatitis C virus expression. Li Y; Zhang T; Ho C; Orange JS; Douglas SD; Ho WZ J Leukoc Biol; 2004 Dec; 76(6):1171-9. PubMed ID: 15339939 [TBL] [Abstract][Full Text] [Related]
16. CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway. Rau SJ; Hildt E; Himmelsbach K; Thimme R; Wakita T; Blum HE; Fischer R Hepatology; 2013 Jan; 57(1):23-36. PubMed ID: 22814930 [TBL] [Abstract][Full Text] [Related]
17. Extracellular HCV-core protein induces an immature regulatory phenotype in NK cells: implications for outcome of acute infection. Golden-Mason L; Hahn YS; Strong M; Cheng L; Rosen HR PLoS One; 2014; 9(7):e103219. PubMed ID: 25076408 [TBL] [Abstract][Full Text] [Related]
18. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells. Plumlee CR; Lazaro CA; Fausto N; Polyak SJ Virol J; 2005 Dec; 2():89. PubMed ID: 16324217 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia impairs anti-viral activity of natural killer (NK) cells but has little effect on anti-fibrotic NK cell functions in hepatitis C virus infection. Wolter F; Glässner A; Krämer B; Kokordelis P; Finnemann C; Kaczmarek DJ; Goeser F; Lutz P; Nischalke HD; Strassburg CP; Spengler U; Nattermann J J Hepatol; 2015 Dec; 63(6):1334-44. PubMed ID: 26297916 [TBL] [Abstract][Full Text] [Related]
20. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis. Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]